<DOC>
	<DOCNO>NCT02747472</DOCNO>
	<brief_summary>Antagonizing GIP effect hyperglycaemia healthy subject measurement insulin secretion .</brief_summary>
	<brief_title>GIP Receptor Antagonist Studies Humans</brief_title>
	<detailed_description>Aim : To evaluate GIP receptor antagonize effect peptide-based competitive GIP receptor antagonist GIP-A ( vs. saline ( placebo ) ) 10 healthy subject 1 hour hyperglycaemic clamp without concomitant iv infusion GIP [ 1-42 ] . The intention establish GIP-A tool eliminate glucose-dependent insulinotropic GIP signalling . The study consist four experimental day ( A-D ) assessment beta cell function 12 mM-hyperglycaemic clamp concomitant infusion A ) GIP [ 1-42 ] , B ) GIP-A , C ) GIP [ 1-42 ] + GIP-A , D ) saline ( placebo ) .</detailed_description>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>Normal kidney function , liver function hemoglobin level . Medication , Diabetes type 1 2 , BMI &gt; 25 , first degree relative Type 2 Diabetes</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>GIP</keyword>
	<keyword>GIP receptor antagonist</keyword>
</DOC>